0001061983-17-000056.txt : 20170908 0001061983-17-000056.hdr.sgml : 20170908 20170908164802 ACCESSION NUMBER: 0001061983-17-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170906 FILED AS OF DATE: 20170908 DATE AS OF CHANGE: 20170908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDowell Caryn Gordon CENTRAL INDEX KEY: 0001674232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 171077059 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-09-06 0 0001061983 CYTOKINETICS INC CYTK 0001674232 McDowell Caryn Gordon 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 GC & Chief Compliance Officer Common Stock 2017-09-06 4 M 0 1432 6.67 A 19801 D Common Stock 2017-09-06 4 S 0 200 14.1 D 19601 D Common Stock 2017-09-06 4 M 0 3067 6.67 A 22668 D Common Stock 2017-09-06 4 S 0 200 14.15 D 22468 D Common Stock 2017-09-06 4 M 0 5732 6.37 A 28200 D Common Stock 2017-09-06 4 S 0 898 14.2 D 27302 D Common Stock 2017-09-06 4 S 0 400 14.25 D 26902 D Common Stock 2017-09-06 4 S 0 100 14.275 D 26802 D Common Stock 2017-09-06 4 S 0 302 14.3 D 26500 D Common Stock 2017-09-06 4 S 0 200 14.35 D 26300 D Common Stock 2017-09-06 4 S 0 200 14.375 D 26100 D Common Stock 2017-09-06 4 S 0 400 14.4 D 25700 D Common Stock 2017-09-06 4 S 0 600 14.45 D 25100 D Common Stock 2017-09-06 4 S 0 200 14.475 D 24900 D Common Stock 2017-09-06 4 S 0 200 14.5 D 24700 D Common Stock 2017-09-06 4 S 0 200 14.525 D 24500 D Common Stock 2017-09-06 4 S 0 200 14.575 D 24300 D Common Stock 2017-09-06 4 S 0 700 14.6 D 23600 D Common Stock 2017-09-06 4 S 0 300 14.625 D 23300 D Common Stock 2017-09-06 4 S 0 200 14.65 D 23100 D Common Stock 2017-09-06 4 S 0 500 14.7 D 22600 D Common Stock 2017-09-06 4 S 0 200 14.725 D 22400 D Common Stock 2017-09-06 4 S 0 600 14.75 D 21800 D Common Stock 2017-09-06 4 S 0 400 14.775 D 21400 D Common Stock 2017-09-06 4 S 0 400 14.8 D 21000 D Common Stock 2017-09-06 4 S 0 100 14.825 D 20900 D Common Stock 2017-09-06 4 S 0 724 14.85 D 20176 D Common Stock 2017-09-06 4 S 0 600 14.9 D 19576 D Common Stock 2017-09-06 4 S 0 400 14.925 D 19176 D Common Stock 2017-09-06 4 S 0 707 14.95 D 18469 D The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017. Caryn McDowell 2017-09-08